Towards eliminating the use of animals from the development of new oral drug formulations
In this project, we use modern tools of computational pharmaceutics such as artificial intelligence and machine learning to guide formulation development. Several larger and smaller companies as well as universities are part of this EU project.
The FHNW School of Life Sciences (Prof. Kuentz) is leading the formulation development work package (WP1).
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 955756.
Stories
Intelligent drug formulation
Martin Kuentz and his students are predicting solubility and formulation composition to reduce animal testing.
Project details
- Type
- Research project
- Research areas
- Oral formulations of chemical drugs
- University
- FHNW School of Life Sciences / Institute for Pharma Technology and Biotechnology
- Partner
- Multiple
- Funding
- This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 955756.
- Running time
- 2020-2024
Contact
Prof. Dr. Martin Kuentz
Team leader Oral formulations of chemical drugs
- Phone
- +41 61 228 56 42
- martin.kuentz@fhnw.ch